Center for Forensic Science Research and Education (CFSRE) at the Fredric Rieders Family Foundation, 2300 Stratford Ave, Willow Grove, PA 19090, USA.
Division of Public Health, North Carolina Department of Health and Human Services, North Carolina Office of the Chief Medical Examiner, 3025 Mail Service Center, Raleigh, NC 27699, USA.
J Anal Toxicol. 2021 Feb 6;45(1):60-68. doi: 10.1093/jat/bkaa054.
Synthetic cannabinoids represent a chemically diverse class of novel psychoactive substances (NPS) responsible for large analytical and interpretative challenges for forensic toxicologists. Between 2016 and 2019, the three most prevalent synthetic cannabinoids in the United States were MMB-FUBINACA (FUB-AMB), 5F-MDMB-PINACA (5F-ADB) and 5F-MDMB-PICA, based on results from seized drug and toxicology testing. In 2018, accurate determination of synthetic cannabinoid positivity was brought into question as it was determined that the metabolites of these drug species were present in the absence of parent compounds in forensically relevant blood samples. During this study, the stability of MMB-FUBINACA, 5F-MDMB-PINACA and 5F-MDMB-PICA was evaluated, as well as the characterization of breakdown products. A liquid-liquid extraction method was assessed for recovery of basic parent compounds and acidic metabolites and deemed fit for use in this study. Analysis was performed by liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) using a SCIEX TripleTOF® 5600+. All three synthetic cannabinoids were found to be unstable when stored in blood at either room temperature or refrigerated; all analytes were considerably more stable when stored in the freezer. All three synthetic cannabinoids degraded to their respective butanoic acid metabolites: MMB-FUBINACA 3-methylbutanoic acid, 5F-MDMB-PINACA 3,3-dimethylbutanoic acid and 5F-MDMB-PICA 3,3-dimethylbutanoic acid. All three of these metabolites were studied and determined to be stable in blood at all storage conditions. Considering these results, our laboratory continued testing for synthetic cannabinoid metabolites in blood samples and found 83 positives (21%) for only a synthetic cannabinoid metabolite. A case report is presented herein where 5F-MDMB-PINACA 3,3-dimethylbutanoic acid was identified in the absence of 5F-MDMB-PINACA. Forensic toxicologists should be aware of the results of this study as they directly impact analytical consideration for test development and implementation, as well as interpretation of findings.
合成大麻素是一类具有不同化学结构的新型精神活性物质(NPS),对法医毒物学家来说,它们在分析和解释方面存在巨大的挑战。在 2016 年至 2019 年期间,根据从缴获的毒品和毒物检测结果,美国最常见的三种合成大麻素是 MMB-FUBINACA(FUB-AMB)、5F-MDMB-PINACA(5F-ADB)和 5F-MDMB-PICA。2018 年,由于这些药物的代谢物在法医相关血液样本中存在而没有母体化合物,因此对合成大麻素阳性的准确测定提出了质疑。在这项研究中,评估了 MMB-FUBINACA、5F-MDMB-PINACA 和 5F-MDMB-PICA 的稳定性,以及分解产物的特征。评估了一种液-液萃取方法来回收碱性母体化合物和酸性代谢物,认为该方法适合用于本研究。使用 SCIEX TripleTOF®5600+ 型液相色谱-四极杆飞行时间质谱(LC-QTOF-MS)进行分析。结果发现,这三种合成大麻素在室温或冷藏条件下保存在血液中时均不稳定;所有分析物在冷冻条件下保存时稳定性都显著提高。这三种合成大麻素都降解为各自的丁酸代谢物:MMB-FUBINACA 3-甲基丁酸、5F-MDMB-PINACA 3,3-二甲基丁酸和 5F-MDMB-PICA 3,3-二甲基丁酸。对这三种代谢物进行了研究,结果表明它们在所有储存条件下在血液中都稳定。鉴于这些结果,我们实验室继续在血液样本中检测合成大麻素代谢物,发现只有代谢物的 83 个阳性(21%)。本文报告了一个案例,其中在没有 5F-MDMB-PINACA 的情况下,检测到 5F-MDMB-PINACA 3,3-二甲基丁酸。法医毒物学家应该了解本研究的结果,因为这些结果直接影响测试开发和实施的分析考虑因素,以及检测结果的解释。